Notably, the IDH2 (R140Q) NRAS (G13R) clone was not predicted from the bulk sequencing VAFs, yet it represented 29% of the diagnosis tumor defined by single-cell DNA sequencing. This evidence concerns the gene NRAS and neoplasm.